- This event has passed.
International Conference on Viral Hepatitis (ICVH 2017)
October 9, 2017 - October 10, 2017
Click here to register online for ICVH 2017.
The 2017 International Conference on Viral Hepatitis (ICVH 2017) will take place October 9-10, 2017, at the Gleacher Center in Chicago. ICVH 2017 is sponsored by the International Association of Providers of AIDS Care (IAPAC), in partnership with the Alliance to Eliminate HIV/HCV Coinfection (AEH2C).
The conference Co-Chairs are Nancy Reau, MD (Rush University Medical Center, Chicago, IL, USA) and Vicente Soriano, MD, PhD (Hospital Carlos III, Madrid, Spain).
Confirmed faculty as of July 14, 2017, include: Kosh Agarwal, MD (King’s College Hospital, London, England); Sanjeev Arora, MD (University of New Mexico, Albuquerque, NM, USA); Michael Charlton, MBBS (Intermountain Transplant and Regenerative Medicine Center, Salt Lake City, UT, USA); Daniel Fierer, MD (Icahn School of Medicine at Mount Sinai, New York, NY, USA); Donald M. Jensen, MD (Rush University Medical Center, Chicago, IL, USA); Natasha Martin, DPhil (University of California, San Diego, CA, USA); Mark Nelson, MD (Chelsea & Westminster Hospital, London, England); Robert Perillo, MD (Baylor University Medical Center, Dallas, TX, USA); Fred Poordad, MD (University of Texas, San Antonio, San Antonio, TX, USA); Kenneth Sherman, MD, PhD (University of Cincinnati, OH, USA); Wendy Spearman, MBChB, MMed, PhD (University of Cape Town, South Africa); Helen S. Te, MD (University of Chicago, IL, USA); Stacy Trooskin, MD (Philadelphia FIGHT Health Centers, Philadelphia, PA, USA); and John Ward, MD (Centers for Disease Control and Prevention, Atlanta, GA, USA).
Featured topics on the ICVH 2017 program will include:
- HBV and HCV Elimination – The Importance of Modeling
- New HBV Therapeutic Perspectives and Options
- HBV Reactivation – Who, When, How?
- Casting a Wider Net to Integrate HCV Care into Primary Care
- Myth Busters – Do DAAs Cause HCC? Reactivate HBV?
- HCV Mechanisms of Sexual Transmission – What Do We Know?
- Acute HCV and its Treatment: Improving Symptoms, Preventing Transmission
- Beyond Cure – Dissecting the HCV Standard of Care
- Resistance to DAAs – Do We Need More HCV Treatment Options?
- Does HCV Therapy with DAAs Prevent or Simply Delay Liver Transplants?
- NASH: The New Epidemic in HIV-Coinfected Patients?
- TAF and HBV/HIV Coinfection – Who, When, How?
- HCV Coinfection – Can We Eliminate HCV without a Focus on MSM?
The conference’s target audience includes liver specialists (hepatologists and gastroenterologists) and infectious disease (ID) and non-ID-specialized physicians, nurses, and pharmacists.
Click here to view the ICVH 2017 program, including confirmed/invited faculty.
Online registration is now open. Early Registration is $100 for IAPAC members and $125 for non-IAPAC members. The Early Registration deadline has been extended to August 18, 2017.
Click here to register online for ICVH 2017.Tags: Conference Hep C Hep C & HIV